-
Ab135101-50μln. Tyr-319 phosphorylation is essential for full activity. Rabbit anti Human ZAP70 Antibody, Recombinant (R01-6H7), could be used for WB and so on.Application:WB: 1/500-1/1000Protein Function:Plays a role in T-cell development and lymphocyte
-
Ab176431-100μgRefanezumab (anti-MAG) is an IgG1-type humanized monoclonal antibody directed against myelin-associated glycoprotein (MAG). Refanezumab (anti-MAG) binds to MAG and blocks MAG-mediated inhibition of axonal regeneration. Refanezumab (anti-MAG) can
-
Ab176431-10mgRefanezumab (anti-MAG) is an IgG1-type humanized monoclonal antibody directed against myelin-associated glycoprotein (MAG). Refanezumab (anti-MAG) binds to MAG and blocks MAG-mediated inhibition of axonal regeneration. Refanezumab (anti-MAG) can
-
Ab176431-1mgRefanezumab (anti-MAG) is an IgG1-type humanized monoclonal antibody directed against myelin-associated glycoprotein (MAG). Refanezumab (anti-MAG) binds to MAG and blocks MAG-mediated inhibition of axonal regeneration. Refanezumab (anti-MAG) can
-
Ab176431-5mgRefanezumab (anti-MAG) is an IgG1-type humanized monoclonal antibody directed against myelin-associated glycoprotein (MAG). Refanezumab (anti-MAG) binds to MAG and blocks MAG-mediated inhibition of axonal regeneration. Refanezumab (anti-MAG) can
-
Ab170950-100μgRilotumumab (anti-HGF) is an anti-HGF (anti-hepatocyte growth factor) monoclonal antibody, inhibits HGF/MET-driven signaling. Rilotumumab (anti-HGF) shows anti-tumor activity, and can be used in castration-resistant prostate cancer (CRPC) and solid
-
Ab170950-10mgRilotumumab (anti-HGF) is an anti-HGF (anti-hepatocyte growth factor) monoclonal antibody, inhibits HGF/MET-driven signaling. Rilotumumab (anti-HGF) shows anti-tumor activity, and can be used in castration-resistant prostate cancer (CRPC) and solid
-
Ab170950-1mgRilotumumab (anti-HGF) is an anti-HGF (anti-hepatocyte growth factor) monoclonal antibody, inhibits HGF/MET-driven signaling. Rilotumumab (anti-HGF) shows anti-tumor activity, and can be used in castration-resistant prostate cancer (CRPC) and solid
-
Ab170950-5mgRilotumumab (anti-HGF) is an anti-HGF (anti-hepatocyte growth factor) monoclonal antibody, inhibits HGF/MET-driven signaling. Rilotumumab (anti-HGF) shows anti-tumor activity, and can be used in castration-resistant prostate cancer (CRPC) and solid
-
Ab176453-100μgRoledumab (anti-RHD) is a human recombinant monoclonal anti-RhD antibody with the potential to prevent RhD allo-immunization.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
-
Ab176453-10mgRoledumab (anti-RHD) is a human recombinant monoclonal anti-RhD antibody with the potential to prevent RhD allo-immunization.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
-
Ab176453-1mgRoledumab (anti-RHD) is a human recombinant monoclonal anti-RhD antibody with the potential to prevent RhD allo-immunization.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg